Evidence map›Paper›PMID 31942068›Full record

ArticleNature2020

VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours.

Eric Song, Tianyang Mao, Huiping Dong, Ligia Simoes Braga Boisserand, Salli Antila, Marcus Bosenberg, Kari Alitalo, Jean-Leon Thomas, Akiko Iwasaki

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Nature, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 356 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
356citing papers in PubMed, 3 pooled it
33.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

356 citing papers in PubMed, 3 syntheses or guidelines pooled it, 509 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Priming of CD8Nature neuroscience · 2026
    Article
  12. Review
  13. Article
  14. Angiogenic Doping: Plausible Yet Difficult to Detect.Sports medicine (Auckland, N.Z.) · 2026
    Review
  15. Article
  16. Review
  17. Article
  18. Mechanisms, Microenvironments, and Models: Understanding Therapeutic Resistance in Glioblastoma.International journal of radiation oncology, biology, physics · 2026
    Review
  19. Review
  20. Review

296 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Eric SongDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Tianyang MaoDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Huiping DongDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Ligia Simoes Braga BoisserandDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA.
Salli AntilaTranslational Cancer Medicine Program and Wihuri Research Institute, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland.
Marcus BosenbergDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Kari AlitaloTranslational Cancer Medicine Program and Wihuri Research Institute, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland.
Jean-Leon ThomasDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA. jean-leon.thomas@yale.edu.
Akiko IwasakiDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA. akiko.iwasaki@yale.edu.
Yale University · USWihuri Research Institute · FIUniversity of Helsinki · FIUniversity of Manchester · GB

Funding

Yale SPORE in Skin CancerP50CA121974 · NCI · YALE UNIVERSITY · PI DAVID F STERN · 2006 to 2026
$43.9M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
Tumor Assessment CoreP01CA128814 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI SMITH, JEFFREY W · 2009 to 2020
$19.1M
Immunity to Genital Herpes Simplex-2R01AI054359 · NIAID · YALE UNIVERSITY · PI IWASAKI, AKIKO · 2004 to 2019
$5.2M
Neurovascular RegenerationR01EB016629 · NIBIB · YALE UNIVERSITY · PI HIRSCHI, KAREN KEMPER · 2014 to 2018
$4.8M
B cell based protection against recurrent herpesR01AI127429 · NIAID · YALE UNIVERSITY · PI IWASAKI, AKIKO · 2017 to 2021
$2.1M
Novel approaches to manipulate sprouting angiogenesisR01EY025979 · NEI · YALE UNIVERSITY · PI EICHMANN, ANNE CHRISTINE · 2015 to 2019
$1.9M
Congenic Mouse Medels of Melanoma for the Characterization of Tumor Immune ResponsesR01CA196660 · NCI · YALE UNIVERSITY · PI BOSENBERG, MARCUS W · 2016 to 2018
$1.7M
Meningeal lymphangiogenesis effect on malignancy ofglioblastoma.F30CA239444 · NCI · YALE UNIVERSITY · PI SONG, HOYEON ERIC · 2019 to 2021
$111k
Howard Hughes Medical InstituteNCI NIH HHS F30 CA239444NCI NIH HHS P01 CA128814NCI NIH HHS P50 CA121974NCI NIH HHS R01 CA196660NEI NIH HHS R01 EY025979NIAID NIH HHS R01 AI054359NIAID NIH HHS R01 AI127429NIBIB NIH HHS R01 EB016629NIGMS NIH HHS T32 GM007205NIH HHS AI054359NIH HHS AI27429NIH HHS CA121974NIH HHS CA128814NIH HHS CA196660NIH HHS R01EB016629-01NIH HHS R01 EY025979-01
6 · The paper itself

Abstract

Immune surveillance against pathogens and tumours in the central nervous system is thought to be limited owing to the lack of lymphatic drainage. However, the characterization of the meningeal lymphatic network has shed light on previously unappreciated ways that an immune response can be elicited to antigens that are expressed in the brain

Indexed as

AnimalsBrain NeoplasmsCD8-Positive T-LymphocytesCell Cycle CheckpointsCell Line, TumorCell MovementCentral Nervous SystemCross-PrimingFemaleGlioblastomaHEK293 CellsHumansImmunologic MemoryImmunologic SurveillanceLymphangiogenesisLymphatic VesselsPDCD1 protein, humanProgrammed Cell Death 1 ReceptorVascular Endothelial Growth Factor C

Identifiers

PMID31942068
PMCPMC7100608
OpenAlexW3000438116

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.